Xequel Bio
PrivateLast Round
Series B
Jan 15, 2018
Total Funding Raised
$15.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Xequel Bio operates in Healthcare & Life Sciences and is based in Mount Pleasant, South Carolina. Its latest recorded funding round was a Series B round in January 2018.
Xequel Bio is a biopharmaceutical company that develops therapeutics for inflammation and injury-based medical conditions using its proprietary alpha-connexin carboxyl-terminus 1 (aCT1) peptide technology platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xequel Bio Comparables
Compare Xequel Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saint Therapeutics | 80% | |
| Scarless Laboratories, Inc. | 79% | |
| Connexin Therapeutics | 65% |
For institutional investors. Book with your work email.
Xequel Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 15, 2018 | ||||
| Grant | Aug 1, 2014 | ||||
| VC Round | Oct 14, 2010 | ||||
| Seed | Sep 1, 2008 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xequel Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| SC Launch | VC Round, Seed |
| Virginia Catalyst | Grant |
| SCRA | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 61% MoM.
- Jan 19, 2026
Monthly visitors increased 90% MoM.
For institutional investors. Book with your work email.
Xequel Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xequel Bio's valuation, stock price, and market status.
Is Xequel Bio a public or private company?
Xequel Bio is a private company.
What is the current stock price of Xequel Bio?
Xequel Bio is a private company, so its shares have no public market price. Caplight tracks Xequel Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xequel Bio worth (valuation)?
Valuation information for Xequel Bio is not publicly available.
Can I buy Xequel Bio stock?
Xequel Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xequel Bio's last funding round?
Xequel Bio's most recent funding round was Series B on January 15, 2018.
Who are the main investors in Xequel Bio?
Key investors in Xequel Bio include NIH RADx, SC Launch, Virginia Catalyst, SCRA.
Will Xequel Bio IPO soon?
No public IPO plans have been announced for Xequel Bio.
How can I track Xequel Bio secondary market activity?
Caplight tracks bids, offers, and trades in Xequel Bio's shares on secondary markets.